Shanghai New World Co., Ltd, founded in 1988 and headquartered in Shanghai, China, operates primarily as a department store retail enterprise, distributing Chinese herbal medicines and selling Chinese patent medicines, western medicines, ginseng and antler tonics, nutritional health products, and medical devices. The company also engages in diversified business activities including hotel management, investment advisory, property and project management, advertising, dining, entertainment, e-commerce, clothing, and trading services across China. It operates over 30 department stores in major Chinese cities, with significant retail presence in Shanghai and Beijing.
Shanghai New World has recently focused on enhancing its retail and service infrastructure by optimizing payment facilitation measures for overseas personnel, expanding its payment device coverage, and upgrading terminals to support foreign card payments, aiming to create a seamless transaction environment. It reported record-breaking revenue of RMB 22 billion in 2024, marking a 15% growth driven largely by retail and shopping mall operations. The company actively invests in sustainable development, smart retail technologies, and has committed to reducing carbon emissions as part of its strategic vision for 2030. It has also embarked on international market expansion, targeting Southeast Asia for 15% revenue growth from overseas operations by 2024.
Its portfolio includes prominent projects in residential and commercial real estate complemented by hotels, reflecting a diversified approach across retail, real estate, and tourism sectors. Shanghai New World's recent notable initiatives include award-winning architectural projects in Shanghai and Ningbo, further underpinning its commitment to innovation and sustainable urban development. The company operates as a subsidiary within the broader New World Group, maintaining leadership in its business segments through continuous expansion and operational modernization.